Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Buy
58
IPHA Quote, Financials, Valuation and Earnings
Last price:
$1.88
Seasonality move
:
-12.28%
Day range:
$1.85 - $1.95
52-week range:
$1.29 - $3.51
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.67x
P/B ratio:
4.93x
Volume:
80.2K
Avg. volume:
997K
1-year change:
-35.62%
Market cap:
$152.2M
Revenue:
$56.2M
EPS (TTM):
-$0.45
Earnings Data
Next earnings date for IPHA
Mar 27
2025
Most recent earnings per share
--
Missed by --
(Jan 8/2025)
Consensus Estimate
--
(Jan 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IPHA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2020 | Q4 | -- | -- | -- | -$0.17 | -- |
| 11/13/2019 | Q3 | -- | -- | -- | $0.05 | -- |
Innate Pharma SA Earnings Questions
-
How Much did Innate Pharma SA Generate in Revenue Last Quarter?
Innate Pharma SA reported -- worth of top line sales in its most recent quarter.
-
Did Innate Pharma SA Beat Earnings Last Quarter?
Innate Pharma SA announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Innate Pharma SA Profitable?
Innate Pharma SA reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Innate Pharma SA EPS Next Year?
Innate Pharma SA's earnings are forecast to decrease from -$0.10 per share to -- per share next year representing a decrease of -55.87%.
-
When is Innate Pharma SA's Earnings Date?
Innate Pharma SA's next earnings date is March 27, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
